Urological cancer, Malmö
1 – 10 of 544
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer : An International, Paired, Noninferiority, Confirmatory Observer Study
(
- Contribution to journal › Article
-
Mark
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research
(
- Contribution to journal › Article
-
Mark
What's in a Name? Why Words Matter in Advanced Prostate Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Randomized trials of PSA screening
(
- Contribution to journal › Scientific review
-
Mark
Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer
(
- Contribution to journal › Article
-
Mark
Acupuncture for Nocturia in Survivors of Prostate Cancer : The NOCTURNAL Randomized Clinical Trial
(
- Contribution to journal › Article
-
Mark
Prostate-specific antigen levels at age 60 and lifetime risk of lethal prostate cancer
2025) In Journal of the National Cancer Institute(
- Contribution to journal › Article
-
Mark
Prostate-Specific Antigen Levels Among Participants Receiving Annual Testing
2025) In JAMA Oncology(
- Contribution to journal › Article
-
Mark
Magnetic resonance imaging for long-term active surveillance biopsy decision-making
(
- Contribution to journal › Article